Evolent Health Inc Cl A Com EVH

$3.43 -0.50 (-12.72%)

Valuation

Market cap
444,507,000
Revenue TTM
$1,876,230,000
Net income TTM
$-534,510,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-28.49%
Debt to equity
2.60

Trading

Volume
3,604,400
Avg volume
2,106,566
Day's range
$3.39 – $3.95
Shares out
113,106,000
Stochastic %K
2%
Beta
1.03
Analysts
Moderate Buy
Price target
$6.00

Price

Company profile

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and lead...

Show more

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Industry
Health Information Services
Sector
Healthcare
Phone
571 389 6000
Website
https://www.evolent.com
Address
1812 N. Moore Street, Suite 1705, Arlington, United States

Latest news

Stocktwits

Merlintrader Nov 20, 1:51 PM
$EVH: Truist upgraded Evolent Health to Buy from Hold and kept a $6 price target, citing valuation after the recent pullback and improved visibility into 2027. Interactive chart with bull and bear scenarios, support/resistance and trendlines on JC Just Charts: https://justcharts.merlintrader.com/#EVH Not investment advice.
0 replies
BPler Nov 20, 1:36 PM
$ANT I hope the liquidity and profits made will go back to biotech/health soon (especially for $EVH and $CRVO were bleeding out hard for me. No surprise in case of CervoMed the CEO just insider bought 100k shares). But it was a big haircut last week. https://www.stocktitan.net/sec-filings/CRVO/form-4-cervo-med-inc-insider-trading-activity-6a88d58b0f17.html
0 replies
briefingcom Nov 20, 1:17 PM
$EVH: Evolent Health upgraded to Buy from Hold at Truist Securities, tgt $6.
0 replies
notreload_ai Nov 20, 11:37 AM
Truist upgrades $EVH to Buy (PT $6): 2027 outlook better, $150M profit more likely. Policy fears overdone; risks mostly priced in. Baird downgrades $PODD to Neutral (PT $158): Pump loyalty falling, more patients may switch. Guggenheim upgrades $OKLO to Buy (PT $38): Encouraged by Q3 progress. Stock down ~80% from Jan high; valuation improved. https://notreload.xyz/wall-street-live-friday-november-20/
0 replies
PatBtmn Nov 19, 7:58 PM
$EVH what a fucking loser!
0 replies
BPler Nov 19, 4:45 PM
$EVH Major health insurers—including UnitedHealth Group (UNH), CVS Health (CVS), and Humana (HUM)—dropped sharply following a new federal proposal to expand Medicare Advantage audits and renewed political pushback on insurer margins. This policy news is the main catalyst behind the sector's steep decline. https://www.techflowpost.com/en-US/article/35499 https://www.marketscreener.com/news/anthropic-s-ipo-revives-ai-sentiment-as-healthcare-stocks-tumble-ce785ed2dd8af725
0 replies
T7_Hldg_Partner Nov 19, 3:10 PM 0 replies
JPetermanAZ Nov 19, 2:19 PM
$EVH why the -25% haircut here this week
0 replies